Sox2 inhibits Wnt-β-catenin signaling and metastatic potency of cisplatin-resistant lung adenocarcinoma cells

Lung cancer remains one of the most common cancer-associated mortalities worldwide, and platinum-based doublet chemotherapies are recommended as the first-line treatment for advanced non-small cell lung cancer (NSCLC). However, the frequent development of multidrug resistance, to cisplatin regimens...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Jinxi, Shi, Juan, Zhang, Kangjian, Xue, Jing, Li, Jing, Yang, Jiali, Chen, Juan, Wei, Jun, Ren, Hong, Liu, Xiaoming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5365002/
https://www.ncbi.nlm.nih.gov/pubmed/28259951
http://dx.doi.org/10.3892/mmr.2017.6170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5365002/
https://www.ncbi.nlm.nih.gov/pubmed/28259951
http://dx.doi.org/10.3892/mmr.2017.6170

Ejemplares similares